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Objectives. This study investigated whether mental stress–
induced vasodilation mediated by endothelium-derived nitric ox-
ide (NO) is defective in conditions with endothelial dysfunction,
such as hypertension and hypercholesterolemia.
Background. Vascular release of NO modulates the vasodilator
response to mental stress in healthy subjects. Previous studies
have shown that hypertensive and hypercholesterolemic patients
have impaired endothelium-dependent vasodilation to pharmaco-
logic agents due to decreased NO activity. However, whether this
abnormality also operates in response to physiologic stimuli such
as mental stress has not been defined.
Methods. Forearm blood flow responses (plethysmography) to
mental stress were compared in 12 normal subjects, 12 hyperten-
sive patients and 10 hypercholesterolemic patients before and
during NO synthesis inhibition with NG-monomethyl-L-arginine
(4 mmol/min). Vascular responses to acetylcholine (7.5, 15 and 30
mg/min), an endothelium-dependent vasodilator, and sodium ni-
troprusside (0.8, 1.6 and 3.2 mg/min), an exogenous NO donor,
were also assessed in each group.
Results. During saline the vasodilator response to mental stress
was significantly blunted in hypertensive (37 6 11%; p 5 0.01) but
not in hypercholesterolemic (85 6 21%; p 5 0.78) patients
compared with controls (93 6 15%). NG-Monomethyl-L-arginine
administration significantly blunted mental stress–induced vaso-
dilation in healthy subjects (p 5 0.004 vs. saline) and hypercho-
lesterolemic patients (p 5 0.03 vs. saline), but not in hypertensive
patients (p 5 0.69 vs. saline). The vasodilator effect of the highest
dose of acetylcholine was similarly blunted in hypertensive (215 6
44%; p 5 0.02) and hypercholesterolemic (172 6 71%; p 5 0.02)
patients compared with controls (364 6 34), whereas the vasore-
laxing response to sodium nitroprusside was similar in the three
groups.
Conclusions. Hypertensive but not hypercholesterolemic pa-
tients have impaired NO-dependent vasodilation during mental
stress. These findings may be accounted for by different mecha-
nisms underlying endothelial dysfunction in these two conditions
and might explain an increased susceptibility of hypertensive
patients to vascular damage over repeated exposure to stressful
situations.
(J Am Coll Cardiol 1998;32:1207–13)
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Endothelial synthesis and release of nitric oxide (NO) play an
important role in the regulation of vascular tone as well as in
the modulation of several processes, such as leukocyte adhe-
sion and platelet aggregation, involved in the pathophysiology
of atherosclerosis (1). In recent years a number of studies have
shown that NO-dependent vasodilator function is impaired in
patients with risk factors for atherosclerosis, such as arterial
hypertension (2–6) and hypercholesterolemia (7–9), suggest-
ing that a decreased bioavailability of NO might play a causal
role in the genesis and progression of the atherosclerotic
disease. However, most of the previous studies investigating
NO-dependent vasodilator activity in humans have used phar-
macologic stimuli as a tool to investigate the ability of the
endothelium to produce NO. It has not been clearly defined,
therefore, whether a decreased production of NO in the
resistance vessels of patients with hypertension and hypercho-
lesterolemia also occurs in response to other physiologic
stimuli.
We and other investigators have recently shown that NO
synthesis inhibition by NG-monomethyl-L-arginine (L-NMMA)
markedly blunts the vasodilator response to mental stress in
the forearm circulation of healthy subjects, thereby suggesting
that this response is partly mediated by local release of NO
(10,11). On the basis of these observations, we hypothesized
that conditions with a demonstrated decrease in NO activity,
such as hypertension and hypercholesterolemia, may also be
associated with reduced vasodilator response to mental stress.
Further, because activities involving mental stress are com-
monly performed several times a day, assessment of the ability
of the vascular endothelium to synthesize and release NO
during stressful situations in patients with hypertension or
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hypercholesterolemia might provide a more relevant estimate
of the pathophysiologic significance of endothelial dysfunction
in these conditions. For this reason, in the present study we
compared the NO-dependent vasodilator response to mental
stress in normal subjects, hypertensive patients and hypercho-
lesterolemic patients.
Methods
Study population. The clinical characteristics and lipid
profile of the subjects who took part in the study are reported
in Table 1.
The hypercholesterolemic group included 10 patients se-
lected for the study because their plasma cholesterol levels
after a 12-h fasting period were greater than 250 mg/dl.
Patients had not taken any cholesterol-lowering agent within
the previous 2 months or any antioxidant vitamin supplement
in the preceding 6 months. No effort was made to change the
patients’ diet before the performance of the study. All hyper-
cholesterolemic patients had normal blood pressure values.
The hypertensive group included 12 patients with a history
of chronically elevated blood pressure (.145/95 mm Hg)
without any apparent underlying cause, who were followed in
the outpatient clinic of the National Heart, Lung and Blood
Institute. Each patient had been previously treated with one or
more antihypertensive agents for more than 3 years. Patients
were asked to discontinue their current antihypertensive ther-
apy 2 weeks before the study day; during that period they were
closely monitored for any evidence of accelerated or malignant
hypertension. Patients in whom the withdrawal of antihyper-
tensive therapy was considered hazardous, mostly because of
severely elevated blood pressure despite medications, were
excluded from the study. All hypertensive patients had plasma
cholesterol levels ,200 mg/dl.
Twelve normal volunteers with no evidence of present or
past hypertension or hypercholesterolemia (total cholesterol
,200 mg/dl) were selected as a control group. They were
matched with the patients of both groups for approximate age
and sex.
Before admission, subjects of each group were screened by
clinical history, physical examination, routine chemical analy-
ses, electrocardiography and chest radiography. Exclusion cri-
teria were history or evidence of present or past diabetes
mellitus, cardiac disease, peripheral vascular disease, coagu-
lopathy or any other disease predisposing them to vasculitis or
Raynaud’s phenomenon.
The study protocol was approved by the National Heart,
Lung and Blood Institute Investigations Review Board, and all
participants gave written informed consent for all procedures.
Protocol. All studies were performed in the morning in a
quiet room with a temperature of approximately 22°C. Partic-
ipants were asked to refrain from drinking alcohol or bever-
ages containing caffeine and from smoking for at least 24 h
before studies.
Each study consisted of the measurement of the response of
the forearm vasculature by means of strain-gauge venous
occlusion plethysmography under different experimental con-
ditions. All drugs used in this study were approved for human
use by the Food and Drug Administration in the form of
Investigational New Drug and were prepared by the Pharma-
ceutical Development Service of the National Institutes of
Health following specific procedures to ensure accurate bio-
availability and sterility of the solutions.
While the participants were supine, a 20-gauge Teflon
catheter (Arrow Inc., Reading, Pennsylvania) was inserted into
the brachial artery of the left arm. This arm was slightly
elevated above the level of the right atrium, and a mercury-
filled Silastic strain gauge was placed in the widest part of the
forearm (12). The strain gauge was connected to a plethysmo-
graph (model EC-4; D.E. Hokanson, Bellevue, Washington)
calibrated to measure the percent change in volume and
connected in turn to a chart recorder to record the flow
measurements. For each measurement a cuff placed around
the upper arm was inflated to 40 mm Hg with a rapid cuff
inflator (model E-10; Hokanson) to occlude venous outflow
from the extremity. A wrist cuff was inflated to suprasystolic
pressures 1 min before each measurement to exclude the hand
circulation (13). Flow measurements were recorded for ap-
proximately 7 s every 15 s; seven readings were obtained for
each mean value.
Table 1. Clinical Characteristics of the Study Population
Normal Subjects
Hypertensive
Patients
Hypercholesterolemic
Patients
Male/female 5/7 7/5 7/3
Age (yrs) 53 6 2 54 6 2 55 6 2
Weight (kg) 77 6 5 83 6 5 74 6 3
Height (cm) 163 6 7 165 6 3 168 6 4
Smoking (yes/no) 0/12 1/11 1/9
Mean arterial pressure (mm Hg) 88 6 2 109 6 3* 88 6 2
Total cholesterol (mg/dl) 185 6 6 163 6 7 292 6 13†
LDL-cholesterol (mg/dl) 117 6 5 117 6 3 215 6 8†
HDL-cholesterol (mg/dl) 51 6 5 496 6 43 6 4
Triglycerides (mg/dl) 76 6 8 111 6 13 207 6 49‡
Data are means 6 SEM. *p , 0.001; †p , 0.001, and ‡p 5 0.008 versus other groups. No significant difference among
groups was observed in the other variables. HDL 5 high-density lipoprotein; LDL 5 low-density lipoprotein.
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Basal measurements were obtained after a 3-min infusion
of saline solution at 1 ml/min. Forearm blood flow was then
measured during mental stress and during the infusion of
sodium nitroprusside. These measurements were separated by
a 30-min resting period. The mental stress testing required
each subject to subtract continuously the number 7 from a
three-digit number as quickly and accurately as possible for
3 min. During the test the participants were intentionally
frustrated by being asked to perform faster and by being
immediately corrected in case of wrong answers. The test
procedure was explained to the subjects upon their arrival in
the laboratory room, and they were asked to practice to get
familiar with the task.
A 30-min rest period was allowed and another forearm
blood flow measurement was obtained to corroborate the
return to basal values. NG-Monomethyl-L-arginine (Calbio-
chem, La Jolla, California) was then infused at 4 mmol/min
(infusion rate, 1 ml/min) for 15 min, and baseline flow mea-
surements were obtained during the last 2 min of infusion.
NG-Monomethyl-L-arginine is an arginine analog that compet-
itively antagonizes the synthesis of NO from L-arginine and
thus provides a tool for investigating the rate of vascular NO
production (14). The mental arithmetic task was subsequently
repeated using the same procedure reported above.
Assessments of vascular responsiveness to acetylcholine
and sodium nitroprusside were performed either on the same
day of mental stress testing or on a different occasion. Acetyl-
choline induces vasodilation by stimulating the release of
relaxing factors from the vascular endothelium (15). Sodium
nitroprusside was used as an endothelium-independent vaso-
dilator because its vasodilator effect is largely due to its direct
action on smooth muscle cells (16). Acetylcholine chloride
(Sigma Chemical Co., St. Louis, Missouri) was infused at 7.5,
15 and 30 mg/min, and sodium nitroprusside was infused at 0.8,
1.6 and 3.2 mg/min (the infusion rates were 0.25, 0.5 and
1 ml/min, respectively, for each drug). Each dose was infused
for 5 min and forearm flow was measured during the last 2 min.
A 30-min rest period was allowed and another basal measure-
ment was obtained between the infusion of the two drugs. The
sequence of acetylcholine and sodium nitroprusside infusion
was randomized to avoid any bias related to the order of these
procedures.
During the study all blood pressures were recorded directly
from the intraarterial catheter immediately after each flow
measurement, and heart rate was recorded from an electro-
cardiographic lead.
Statistical analysis. Group differences were analyzed by
one-way analysis of variance and by chi-square test as appro-
priate. The effects of L-NMMA on vascular responses to
mental stress within each group were analyzed by paired
Student t test. Group differences in the dose–response curves
to acetylcholine and sodium nitroprusside were analyzed by
analysis of variance for repeated measures. All calculated p
values are two-tailed, and a p value less than 0.05 was
considered to indicate statistical significance. All group data
are reported as means 6 SEM.
Results
Clinical characteristics and baseline measurements. The
clinical characteristics of the subjects in the three study groups
are indicated in Table 1. There was no significant difference
among the three groups in sex, age, weight, height and smoking
habit. As expected, mean arterial pressure was higher in
hypertensive patients than in the other groups, and total
cholesterol and low-density lipoprotein cholesterol were
higher in hypercholesterolemic patients than in the other
groups. Baseline forearm blood flow was not significantly
different (p 5 0.63) among the three group (Table 2).
Hemodynamic responses to mental stress. During infusion
of saline, mental stress testing induced an increase in forearm
blood flow from baseline in each group (Table 2). The
vasodilator response to mental stress testing was significantly
reduced in hypertensive but not in hypercholesterolemic pa-
tients compared with controls (Fig. 1).
Mental stress testing caused an increase in mean arterial
Table 2. Hemodynamic Variables at Baseline and During Mental Stress Testing Before and After Nitric Oxide Synthesis Inhibition
Saline L-NMMA (4 mmol/min)
Normal
Subjects
Hypertensive
Patients
Hypercholesterolemic
Patients
Normal
Subjects
Hypertensive
Patients
Hypercholesterolemic
Patients
Forearm blood flow
(ml/min/dl)
Baseline 2.9 6 0.2 3.2 6 0.2 3.2 6 0.3 2.6 6 0.4 2.7 6 0.1 2.2 6 0.2
Mental stress 5.5 6 0.6 4.3 6 0.4 6.0 6 0.9 3.4 6 0.3 3.46 0.2 2.96 0.2
Mean arterial pressure
(ml/min/dl)
Baseline 88 6 3 109 6 3 88 6 2 89 6 2 111 6 3 91 6 3
Mental stress 104 6 3 129 6 3 114 6 3 105 6 3 126 6 3 109 6 4
Heart rate (beats/min)
Baseline 65 6 3 63 6 3 63 6 2 64 6 3 65 6 3 65 6 2
Mental stress 81 6 4 81 6 3 83 6 2 81 6 4 79 6 4 79 6 2
Data are means 6 SEM.
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pressure from baseline in each group (Table 2) without any
significant difference among them (p 5 0.69). Similarly, the
performance of mental arithmetic caused an increase in heart
rate over baseline in each group (Table 2) without any
significant difference among them (p 5 0.66).
Effects of L-NMMA on hemodynamic responses to mental
stress. During L-NMMA administration, the performance of
mental stress testing resulted in an increase in forearm blood
flow from baseline in all groups (Table 2). In both controls and
hypercholesterolemic patients, however, the vasodilator re-
sponse to the performance of mental arithmetic test was
significantly lower during NO synthase inhibition than during
saline (Fig. 2). In contrast, in hypertensive patients the in-
crease in forearm blood flow induced by mental stress was not
significantly different during saline or L-NMMA administration
(Fig. 2). As a result, the vasodilator effect of mental stress
testing during NO synthesis inhibition was not significantly
different among the three groups. (p 5 0.49).
During L-NMMA administration, mean arterial pressure
and heart rate values during mental stress testing (Table 2)
were not significantly different among the three groups (p 5
0.70 and p 5 0.95 for mean arterial pressure and heart rate,
respectively), and within each group they were similar to those
observed during saline infusion (all p . 0.05).
Forearm blood flow responses to acetylcholine and sodium
nitroprusside. Infusion of increasing doses of acetylcholine
resulted in a progressive increase in forearm blood flow from
baseline in the three groups (Table 3); the vasodilator response
to acetylcholine, however, was significantly blunted in hyper-
tensive and hypercholesterolemic patients compared with con-
trols (Fig. 3). Sodium nitroprusside administration induced a
dose-dependent vasodilator response in each group (Table 3);
in contrast with acetylcholine results, however, the vasodilator
response to sodium nitroprusside was not significantly different
among the three groups (Fig. 3).
Discussion
The results of this study demonstrate that, compared with
healthy subjects, hypertensive but not hypercholesterolemic
Figure 1. Bars show the percent changes in forearm blood flow from
baseline in response to mental stress in normotensive, hypertensive
and hypercholesterolemic subjects. Values represent mean 6 SEM.
Figure 2. Bars show the effect of nitric oxide synthesis inhibition by
NG-monomethyl-L-arginine (L-NMMA, 4 mmol/min) on the percent
changes in forearm blood flow from baseline in normotensive, hyper-
tensive and hypercholesterolemic subjects. Values represent mean 6
SEM. Open box 5 saline; solid box 5 L-NMMA.
Table 3. Forearm Blood Flow Responses to Intraarterial Infusion of
Increasing Doses of Acetylcholine and Sodium Nitroprusside
Normal
Subjects
Hypertensive
Patients
Hypercholesterolemic
Patients
Acetylcholine
7.5 mg/min 7.5 6 1.1 5.9 6 1.1 3.3 6 0.4
15 mg/min 9.7 6 1.1 8.1 6 1.5 5.4 6 1.7
30 mg/min 14.4 6 1.2 9.9 6 1.5* 7.6 6 2.5†
Sodium nitroprusside
0.8 mg/min 7.1 6 0.7 6.2 6 0.4 5.9 6 0.5
1.6 mg/min 8.6 6 0.8 8.1 6 0.5 7.3 6 0.6
3.2 mg/min 11.6 6 1.1 11.2 6 0.5 10.4 6 0.8
Data are means 6 SEM. *p , 0.001 and †p , 0.001 versus normal subjects.
No significant difference among groups was observed in the vasodilator response
to sodium nitroprusside.
Figure 3. Bars show the percent changes in forearm blood flow from
baseline in response to intraarterial infusion of acetylcholine (30
mg/min) and sodium nitroprusside (3.2 mg/min) in normotensive (NV),
hypertensive (HT) and hypercholesterolemic (HC) subjects. Values
represent mean 6 SEM.
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patients have a blunted vasodilator response to mental stress.
Nitric oxide synthase inhibition by L-NMMA significantly
reduced mental stress–induced vasodilation in healthy subjects
and hypercholesterolemic patients, but did not induce any
significant change in hypertensive patients; as a result, during
NO synthesis inhibition the vasomotor response to mental
stress was similar in all groups. These findings indicate that the
defect in the vasodilator responsiveness to mental stress testing
observed in hypertensive patients is related to decreased NO
activity, whereas the bioavailability of NO during mental stress
is normal in hypercholesterolemic patients. In contrast with
these results, endothelium-dependent vasodilator responses to
acetylcholine were similarly impaired in hypertensive and
hypercholesterolemic patients. On the other hand,
endothelium-independent vasodilator responsiveness to so-
dium nitroprusside was similar in patients and controls,
thereby indicating that the generalized impairment of
endothelium-dependent vasodilation observed in hypertensive
patients is specifically accounted for by a defect in endogenous
NO activity, because the ability of vascular smooth muscle to
respond to exogenous NO is preserved. Of note, blood pres-
sure and heart rate responses to mental stress were not
different among the three groups and were not significantly
affected by L-NMMA. These observations indicate that the
systemic hemodynamic response elicited by mental stress was
similar in all groups and was not affected by NO inhibition,
thus enhancing the specificity of group differences in mental
stress–induced vasodilation and in the effects of L-NMMA on
this response.
Pathophysiologic mechanisms. Previous studies in our lab-
oratory have suggested the possibility of different abnormali-
ties underlying the defect in NO activity in patients with
hypertension and hypercholesterolemia. Thus, although both
hypertensive and hypercholesterolemic patients have impaired
vasodilator response to acetylcholine, the vasorelaxing effect of
bradykinin, another endothelium-dependent vasodilator, is
selectively impaired in hypertensive (17) but not in hypercho-
lesterolemic (18) patients. Moreover, an increased production
of superoxide anions through the xanthine oxidase pathway
seems to be partially responsible for the decreased NO bio-
availability in hypercholesterolemic but not in hypertensive
vessels (19). The results of this study confirm and expand these
previous observations by demonstrating that hypercholester-
olemic and hypertensive patients have a different NO-
mediated vasodilator response to a physiologic stimulus such
as mental stress.
To shed light on the nature of the selective abnormality in
NO-mediated vasodilator responsiveness to mental stress ob-
served in hypertensive compared with hypercholesterolemic
patients, it is necessary to analyze the potential mechanisms
involved in NO release during this task. It has been proposed
that acetylcholine released from cholinergic nerves could be
involved in the vasodilator effect of mental stress because
vasodilation is significantly blunted by atropine administration
(10). Although in our study both hypertensive and hypercho-
lesterolemic patients had blunted vasodilator response to
exogenous acetylcholine, it cannot be excluded that the release
of acetylcholine from cholinergic nerve endings during mental
stress was reduced in hypertensive patients. In addition, other
mechanisms independent of cholinergic nerve stimulation
seem to contribute to NO release in response to mental stress,
as suggested by previous evidence showing that the combined
infusion of atropine and L-NMMA results in a further decrease
of mental stress–induced vasodilation compared with atropine
alone (10). One possible explanation of this phenomenon is the
activation by mental stress of autonomic neurons releasing or
coreleasing neurotransmitters different from the classic adren-
ergic and cholinergic mediators. Among the variety of nonad-
renergic, noncholinergic neurons identified in recent years,
peptidergic nerves (releasing substance P) and nitrergic nerves
(releasing NO) are present in several perivascular beds of
different species, where they contribute to the regulation of
vasomotor tone (20). It is therefore possible that NO released
from vascular endothelium in response to stimulation of
tachykinin receptors released by nitrergic nerves, or both,
might participate in the physiologic adaptation to mental
stress, and such a mechanism could be impaired in patients
with essential hypertension.
Another mechanism that might contribute to NO-mediated
vasodilation during mental stress is the stimulation of alpha2-
(21,22) or beta2-adrenoceptors (23,24), or both, on endothelial
cells after the increase in catecholamine levels (25). Although
a recent study in our laboratory has shown that NO production
in response to beta-adrenoceptor stimulation is similar in
hypertensive patients and healthy controls (26), a possible
impairment of alpha2-adrenoceptor–mediated release of NO
in hypertensive patients cannot be excluded. Also, potential
differences in local or systemic catecholamine release in hy-
pertensive patients leading to a defect in catecholamine-
stimulated NO release or alternatively an increased vascular
smooth muscle constrictor responsiveness to catecholamines
could also explain our results.
Finally, a phenomenon that is possibly involved in NO
release during mental stress is flow-mediated vasodilation as a
consequence of mental stress–induced increase in cardiac
output. This mechanism is suggested by the findings of a
previous study, showing that mental stress–induced vasodila-
tion is inhibited by systemic administration of selective beta-
adrenergic blocking agents (27), which do not affect beat2-
adrenoceptor–mediated peripheral vasodilation, thus implying
that preventing cardiac output increase might blunt the rise in
limb blood flow in response to mental stress. Flow and shear
stress are known to stimulate constitutive endothelial NO
synthase (eNOS) by inducing a series of mechanochemical
signal transduction events involving G protein activation and
increase in intracellular levels of inositoltriphosphate (28–31).
Previous studies have shown that flow-mediated vasodilation is
impaired in the conductance arteries of hypercholesterolemic
patients (32,33) and relatively preserved in those of hyperten-
sive patients (34,35). Therefore, it is unlikely that an impair-
ment of this mechanism in resistance arteries of hypertensive
patients explains their blunted NO-mediated vasodilator re-
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sponse to mental stress observed in our study. However,
because those reports (32–35) are related to the response of
large conductance arteries, whereas our study addresses the
behavior of the microvasculature, this possibility cannot be
completely ruled out.
Despite the presence of reduced NO-dependent vasodilator
responsiveness to mental stress in our hypertensive study
patients, the pressor response to psychologic challenge was not
different among the three groups. Because the blood pressor
response to mental stress may be achieved by variable combi-
nations of changes in cardiac output and peripheral resistance
(36), our findings are probably explained by a different pattern
of hemodynamic reactivity in hypertensive patients, with
higher peripheral resistance and lower cardiac output in-
creases, as previously reported by other investigators (36).
The findings of this investigation point out a potential
pathophysiologic mechanism through which stressful situations
may lead to untoward acute and chronic cardiovascular effects
in patients with arterial hypertension. Thus, defective endothe-
lial release of NO in hypertensive vessels may amplify the
deleterious effect of hemodynamic and hemostatic changes
induced by mental stress and lead to those plaque complica-
tions that underlie the occurrence of acute cardiovascular
events. Under these conditions, repeated exposure to environ-
mental stress may present a stronger stimulus for vascular
injury, with consequent acceleration in the development of
atherosclerosis and its complications.
It must be noted, however, that because of the heterogene-
ity of essential hypertension, the reduced vasodilator response
to mental stress might not be a generalized finding, but may be
limited only to a subset of hypertensive patients. This possibil-
ity is suggested by the results of a previous study showing that
normotensive subjects and hypertensive patients have a similar
vasodilator response to mental stress induced by the Stroop
color–word test (37). Although the precise reason for this
discrepancy is unknown, it might be hypothesized that the
different mental stress protocol used in the two studies could
have influenced the results, as suggested by a recent study
showing a lower degree of sympathetic activation during the
Stroop test as compared with another active coping task (38).
Our study participants could have experienced a lower level
of stress during the second exposure to the psychologic chal-
lenge (during L-NMMA administration) as they became famil-
iar with the demands of the experiment (39). Care was taken to
avoid this phenomenon by allowing all subjects and patients to
practice before the performance of the tasks, thus minimizing
the possibility of adaptation of the cardiovascular response to
stress testing over repeated exposure. Because plasma cate-
cholamine levels were not measured in our study, we do not
have direct evidence that the two mental stress experiments
evoked the same magnitude of sympathetic response. How-
ever, it must be noted that blood pressure and heart rate
responses were similar between the two tasks in all groups,
thus suggesting that the degree of systemic hemodynamic
responsiveness to mental stress did not decrease over time.
Conclusions. Our study indicates that hypertensive but not
hypercholesterolemic patients have impaired NO-dependent
vasodilation during mental stress. These findings may be
accounted for by different mechanisms underlying endothelial
dysfunction in these two conditions and might explain an
increased susceptibility of hypertensive patients to vascular
damage over repeated exposure to stressful situations.
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